Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)
 
 • Company Description   
agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States.

Number of Employees: 856

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.59 Daily Weekly Monthly
20 Day Moving Average: 8,903,215 shares
Shares Outstanding: 414.87 (millions)
Market Capitalization: $244.48 (millions)
Beta: 0.11
52 Week High: $6.08
52 Week Low: $0.34
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -29.19% -28.57%
12 Week -9.64% -9.76%
Year To Date -14.43% -14.85%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
440 Polaris Parkway Suite 550
-
Westerville,OH 43082
USA
ph: 562-256-3800
fax: -
investors@agilonhealth.com http://agilonhealth.com
 
 • General Corporate Information   
Officers
Ronald A. Williams - Chairman
Ravi Sachdev - Vice Chairman
Jeffrey Schwaneke - Chief Financial Officer
Timothy Gertsch - Chief Accounting Officer
Sharad Mansukani - Director

Peer Information
Agilon Health, Inc. (CHCR)
Agilon Health, Inc. (ESRX)
Agilon Health, Inc. (MYDP)
Agilon Health, Inc. (COR)
Agilon Health, Inc. (GBCS)
Agilon Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 00857U107
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/05/26
Share - Related Items
Shares Outstanding: 414.87
Most Recent Split Date: (:1)
Beta: 0.11
Market Capitalization: $244.48 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.39 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 38.59% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/05/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.93
Price/Cash Flow: -
Price / Sales: 0.04
EPS Growth
vs. Year Ago Period: -84.00%
vs. Previous Quarter: -70.37%
Sales Growth
vs. Year Ago Period: 3.09%
vs. Previous Quarter: 9.35%
ROE
12/31/25 - -120.82
09/30/25 - -75.92
06/30/25 - -66.76
ROA
12/31/25 - -24.89
09/30/25 - -18.35
06/30/25 - -17.47
Current Ratio
12/31/25 - 1.02
09/30/25 - 1.08
06/30/25 - 1.16
Quick Ratio
12/31/25 - 1.02
09/30/25 - 1.08
06/30/25 - 1.16
Operating Margin
12/31/25 - -6.83
09/30/25 - -5.44
06/30/25 - -5.53
Net Margin
12/31/25 - -6.60
09/30/25 - -5.24
06/30/25 - -5.35
Pre-Tax Margin
12/31/25 - -6.81
09/30/25 - -5.46
06/30/25 - -5.55
Book Value
12/31/25 - 0.31
09/30/25 - 0.74
06/30/25 - 0.99
Inventory Turnover
12/31/25 - -
09/30/25 - -
06/30/25 - -
Debt-to-Equity
12/31/25 - 0.12
09/30/25 - 0.00
06/30/25 - 0.00
Debt-to-Capital
12/31/25 - 11.05
09/30/25 - 0.00
06/30/25 - 0.00
 

Powered by Zacks Investment Research ©